FGFR4 and chronic kidney disease: Studies that assessed cardiac metabolism in CKD are scarce and mostly addressed single metabolic pathways.42–46 In contrast, we used an agnostic approach to report on global changes in cardiac amino acids, acylcarnitines and organic acid metabolism in wild-type and FGFR4-deficient mice.